NEW HAVEN, CT — Sickle cell disease (SCD) patients who utilize medicinal cannabis require fewer hospitalizations as compared to SCD patients who refrain from the substance, according to clinical data published in the journal Blood. Investigators from Yale University in Connecticut and from the Sackler School of Medicine in Israel compared rates of hospital admissions over a six-month […]
Adults with a history of cannabis use are less likely to suffer from non-alcoholic fatty liver disease (NAFLD) than are those who have not used the substance, according to data published online in the journal PLoS One. Non-alcoholic fatty liver disease is the most prevalent form of liver disease, affecting an estimated 80 to 100 […]
SAN FRANCISCO, CA — Neither current nor the long-term cumulative use of cannabis is associated with negative effects on the kidneys, according to longitudinal data published online ahead of print in the Clinical Journal of the American Society of Nephrology. Investigators at the San Francisco Veterans Affairs Medical Center and the University of California, San Francisco assessed the […]
Rochester, NY (PRWEB) February 11, 2015
“Infected with the human papillomavirus (HPV)? The CBCD, which conducted two separate post-marketing clinical studies on the natural, antiviral formula of Novirin, recommends taking this effective HPV remedy to help the immune system target the latent HSV virus.” – Greg Bennett, CBCD
Research shows that men who have sex with men (MSM) have higher rates of HPV infection in the mouth. This is important to note since oral infection with the high-risk HPV-16 is now known to be a cause of head and neck cancer. During the study it was found that “oral high-risk HPV infection was significantly associated with a higher number of recent oral sex partners among MSM overall … (and) … oral-anal contact in the previous six months was significantly associated with incident oral high-risk HPV infection….” (1) For HIV infected men, the rates of HPV infection are even higher. “A much higher prevalence of up to 25% has been reported among HIV-infected men who have sex with men (MSM).” For these individuals, risk factors included “a higher number of recent oral sex partners and both recent tobacco smoking and cannabis use were associated with incident oral high-risk HPV infection in multivariable analyses.” (1) The CBCD recommends that HPV infected men take Novirin. This HPV remedy was shown to effectively reduce HPV symptoms in two separate post-marketing clinical studies that followed FDA guidelines.
Click to learn more about HPV symptoms.
The formula of Novirin was tested by Hanan Polansky and Edan Itzkovitz from the CBCD. The studies showed that the Novirin formula is effective against the human papillomavirus (HPV). The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with HPV…reported a safe decrease in their symptoms following treatment….” (2) The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (2)
Novirin can be ordered on the product website here: http://www.novirin.com
Novirin is a natural antiviral dietary supplement. Its formula contains five natural ingredients: Selenium, Camellia Sinensis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Novirin is the only natural antiviral product on the market with published clinical studies on its formula that supports its claims.
Men have weaker immune responses to the human papillomavirus (HPV) in comparison to women (See Urologic Oncology: Seminars and Original Investigations, from January 2014) (3). In other words, male immune systems are unable to control the latent HPV as efficiently. “This is supported by serologic studies (studies of the blood) that find a higher prevalence of HPV antibodies (proteins used by the immune system) in women than in men across all ages (3).”
New HPV infections are found in up to 39% of men every year (3). In men with healthy immune systems, HPV infections are cleared in 6 months or longer. However, in about 10% of all cases, when men have a weak immune system, HPV infections will persist. This can cause a variety of serious health problems. (See the CDC website last updated on July 25, 2013) (4).
For men, an HPV infection can lead to conditions, including genital warts, penile, anal, and oropharyngeal cancer (head and neck cancer) (4).
The CDC notes that “HPV may … be passed on during oral sex and genital-to-genital contact. HPV can be passed on between straight and same-sex partners-even when the infected partner has no signs or symptoms.” (See the CDC’s Website, last updated on February 5, 2013) (5).
What treatments are currently available against the HPV?
“There are no drugs approved against the HPV. Current treatments include procedures, such as cryotherapy, conization, and the Loop Electrosurgical Excision Procedure (LEEP). These procedures use liquid nitrogen, a surgical knife (scalpel), a carbon dioxide (CO2) laser, or electrical current to remove the abnormal growths caused by the HPV. These growths include cells that harbor the active virus. The procedures do not target cells with the latent virus. Since they do not remove the latent virus, these procedures only produce a temporary remission.” (5) In contrast, the formula of Novirin was designed to target the latent HPV.
Click to learn more about Novirin and HPV.
All orders of Novirin are completely confidential and no information is shared or sold to any third party. Privacy is assured.
(1) van Aar F, Mooij SH, van der Sande M, Meijer C, King AJ, Verhagen D, Heijman T, Coutinho RA, Schim van der Loeff MF. “Twelve-month incidence and clearance of oral HPV infection in HIV-negative and HIV-infected men who have sex with men: the H2M cohort study.” BMC Infect Dis. 2014 Dec 31;14(1):3845.
(2) Polansky, H. Itzkovitz, E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013.
(3) Amber Flaherty, M.D.a, Timothy Kim, M.D.b, Anna Giuliano, Ph.D.c, Anthony Magliocco, M.D., Ph.D.d, Tariq S. Hakky, M.D.b, Lance C. Pagliaro, M.D.e, Philippe E. Spiess, M.D., M.S. “Implications for human papillomavirus in penile cancer.” Urologic Oncology: Seminars and Original Investigations. Published in January 2014.
(4) CDC – Sexually Transmitted Diseases (STDs) – Genital HPV Infection – Fact Sheet. Last updated on July 25, 2013.
(5) CDC – Human Papillomavirus (HPV) – What is HPV? Last updated on February 5, 2013.